Plain-English translation of NCT07345247 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing a treatment called radiation segmentectomy with resin microspheres for people with liver cancer. In this procedure, tiny radioactive resin beads are infused directly into the blood vessels supplying the tumor, delivering high-dose radiation precisely to the cancer while sparing healthy liver tissue. The trial aims to prove that this treatment is both safe and effective, and to determine the best radiation doses for the best results.
Most doctors currently use glass microspheres for this type of treatment, but recent research suggests resin microspheres may work just as well—or even better—at lower radiation doses. This trial exists to gather solid evidence that could change medical practice and help more liver cancer patients benefit from this potentially less toxic approach.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive the radiation segmentectomy procedure with resin microspheres, performed by the study team at their center. After treatment, you will undergo imaging scans (PET scans) to track how well the radiation was delivered and how your tumor responds. You will need to return for follow-up visits to monitor your safety and the effectiveness of the treatment, and the study team will use imaging and dosimetry calculations to measure how much radiation your tumor received.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Turkey (Türkiye)